Biolide
Weight Management Treatment
Works by acting on receptors in the brain that controls your appetite, causing you to feel fuller and less hungry.
Liraglutide
Biocon
Management of Type 2 Diabetes
Helps your body reduce your blood sugar level only when blood sugar is too high
Liraglutide: A Groundbreaking Medication for Type 2 Diabetes and Chronic Obesity
Liraglutide is an innovative GLP-1 receptor agonist used to treat type 2 diabetes and chronic obesity. By increasing insulin release from the pancreas and reducing the production of excess glucagon, Liraglutide helps control blood sugar and manage weight effectively.
In 2024, Biocon Limited became the first generics company to receive regulatory approval for Liraglutide in the UK to treat diabetes and obesity, marking a significant milestone. This approval underscores Biocon’s expertise in producing complex peptides and delivering affordable, high-quality medications to patients worldwide.
Key Benefits of Liraglutide
Improved Glycemic Control
Helps manage blood sugar levels in patients with type 2 diabetes by stimulating insulin production and inhibiting excess glucagon.
Weight Management
Proven to support sustainable weight loss by reducing appetite and promoting satiety in patients with chronic obesity.
Global Accessibility
With Biocon’s regulatory approval in the UK, high-quality, affordable Liraglutide generics are now accessible to more patients.
Biolide
For Weight Management
Indication
It can be used for weight loss in conjunction with diet and exercise in adults aged 18 and above who either have a BMI of 30 kg/m² or greater (obesity), or a BMI of 27 kg/m² and less than 30 kg/m² (overweight), or those with weight-related health problems.
How It Works
Reduces appetite by acting on receptors in the brain.
Results
5%+
body weight reduction in 12 weeks on the 3.0 mg/day dose.